Hong Jun Liang
Director/Board Member at BEIJING STRONG BIOTECHNOLOGIES,INC.
Hong Jun Liang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Director/Board Member | 12/08/2020 | - |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 14/09/2020 | - |
Career history of Hong Jun Liang
Former positions of Hong Jun Liang
| Companies | Position | Start | End |
|---|---|---|---|
| JIANGSU HENGRUI MEDICINE CO., LTD. | Director/Board Member | 12/11/2018 | 31/12/2019 |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Chairman | - | 14/11/2019 |
Statistics
International
| China | 5 |
Operational
| Director/Board Member | 3 |
| Chairman | 1 |
Sectoral
| Health Technology | 4 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Private companies | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Stock Market
- Insiders
- Hong Jun Liang
- Experience
